Merck Life Science A/S: Financial statements 2025
CVR: 20830131
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Merck Life Science A/S (CVR 20830131) has filed annual accounts for 2025. In 2025, the company reported revenue of DKK 1,748,796,583 and a net result of DKK 79,492,665 compared with DKK 66,730,278 the year before. That is an increase of 13.8% compared with the year before. The profit margin was 4.5%. Equity in the 2025 report amounted to DKK 226,078,413. The solvency ratio was 70.1%. The company had 22 employees in the financial year.
- Revenue
- DKK 1,748,796,583
- Gross Profit
- DKK 130,557,841
- Profit/Loss
- DKK 79,492,665
- Equity
- DKK 226,078,413
- Total Assets
- DKK 322,510,851
- Employees
- 22
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | 1.7B | 130.6M | 79.5M | 226.1M | 22 |
| 2024 | 1.5B | 108.7M | 66.7M | 216.6M | 23 |
| 2023 | 1.4B | 119.8M | 73.6M | 239.9M | 24 |
| 2022 | 1.3B | 80.1M | 46M | 166.2M | 20 |
| 2021 | 1B | 69.8M | 37.7M | 214.7M | 16 |
Official annual report
How creditworthy is Merck Life Science A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Merck Life Science A/S has published its annual report for 2024. Revenue came to DKK 1,536,249,249, and the net result was DKK 66,730,278.
About Merck Life Science A/S
Merck Life Science A/S is a Danish company of the type Aktieselskab based in Søborg, founded in 1998. The company is registered under the industry Engroshandel med andre maskiner og andet udstyr. The company was previously named SIGMA-ALDRICH DENMARK A/S and SIGMA-ALDRICH DENMARK ApS. The management consists of Janecke Stokkebokjær Lundring. The board consists of Anders Gerner Petersen (chair), Janecke Stokkebokjær Lundring and Tiina Marjatta Puhakka. The company is owned by Merck Life Science N.V. The company has 24 employees (2026). In 2025, the company reported revenue of DKK 1,748,796,583 and a net result of DKK 79,492,665 compared with DKK 66,730,278 the year before. Equity in the 2025 report amounted to DKK 226,078,413.
